CNETS Canada is committed to improving the quality of life and survival for NET patients across Canada. To deliver on this vision, CNETS Canada has been supporting NET-research since 2011, initially through a partnership-based approach and since 20016 through our independent Research Funding Framework. This is the third year in which we are offering research grants across Canada for NET research based on our famework.
The NET patient community has continually demonstrated a strong commitment to supporting CNETS Canada’s fundraising efforts. In March CNETS Canada reached out to the patient community through an online, anonymous survey to gather feedback and input on setting the research priorities for CNETS Canada sponsored grants for the next 2-3 years.
We received close to 200 responses from across Canada with 75% of the replies from patients. One of the most significant findings was 90% of respondents who have donated to NET research in the past, will continue to support NET cancer research in the future. 75% of respondents indicated the motivating factor for donating to NET research is “hoping for a cure”. When asked where should research funds be directed towards the community priorities were, clinical trials (74%), immunotherapy (50%), PRRT (48%), Ga68 (47%) and basic science (33%).
In 2016 and 2017 CNETS Canada awarded 2 NET research grants per year, based on the research funds that were raised. For 2018, CNETS Canada is thrilled to announce that 3 NET research grants will be awarded, thanks to the tremendous fundraising efforts of Bailey and Jonathan Daniels.
In their honour, this NET research grant will be named The Daniels Constellation Fund for Neuroendocrine Cancer Research
. Bailey, a NET cancer patient, and her husband Jonathan are an amazing example of how two people can truly make a difference. Along with their friends, families and supporters they have made an incredibly meaningful contribution to the NET community through their fundraising activities. We extend our sincere thanks to them for choosing to direct their funds towards NET cancer research.
The 2018 Neuroendocrine Tumour Research Grant will provide grant-in-aid for THREE projects up to a maximum of $40,000 per project.
2018 ELIGIBILITY CRITERIA
Relevance of the application to the focused area of Neuroendocrine Tumour (NET) research.
The eligible project must involve a clinical trial or a clinical or fundamental research project (including animal or cellular models) to examine issues relevant for the understanding of the origin and development of Neuroendocrine tumors (NETs), their diagnosis and treatment.
The onus is on the applicant to justify the request in terms of its relevance to the diagnosis and therapy for NET patients by these selected approaches.